Skip to main content
. 2018 Mar 30;2(5):515–528. doi: 10.1002/hep4.1168

Figure 2.

Figure 2

Probability of survival without a poor outcome after PEBD, by mutation group. Patients were followed from PEBD to the first poor outcome (progression to cirrhosis, listing for or receiving a liver transplant, or dying) or last follow‐up. Number at risk reflects the number of patients remaining at risk for a poor outcome at each time point.